Outrage of the Month: Industry Lawsuit Threatens FDA's Regulation of Drugs (POLITICS)
On May 7, Amarin Pharma filed an unusual lawsuit against the Food and Drug Administration (FDA), arguing that the agency's drug regulations violate the company's First Amendment free-speech rights. If Amarin prevails in its litigation, the repercussions for patient and public health will be dire.